XML 15 R6.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Statements of Stockholders' Equity - USD ($)
$ in Thousands
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2021 $ 2 $ 180,067 $ (152,831) $ 27,238
Balance (in shares) at Dec. 31, 2021 19,858,460      
Increase (Decrease) in Stockholders' Equity        
Exercise of stock options   69   69
Exercise of stock options (in shares) 15,830      
Issuance of common stock under stock incentive plans (in shares) 96,496      
Stock-based compensation expense   824   824
Net income (loss)     1,935 1,935
Balance at Mar. 31, 2022 $ 2 180,960 (150,896) 30,066
Balance (in shares) at Mar. 31, 2022 19,970,786      
Balance at Dec. 31, 2021 $ 2 180,067 (152,831) 27,238
Balance (in shares) at Dec. 31, 2021 19,858,460      
Increase (Decrease) in Stockholders' Equity        
Net income (loss)       3,606
Balance at Jun. 30, 2022 $ 2 182,488 (149,225) 33,265
Balance (in shares) at Jun. 30, 2022 20,137,520      
Balance at Mar. 31, 2022 $ 2 180,960 (150,896) 30,066
Balance (in shares) at Mar. 31, 2022 19,970,786      
Increase (Decrease) in Stockholders' Equity        
Exercise of stock options   50   50
Exercise of stock options (in shares) 18,131      
Issuance of common stock under stock incentive plans   167   167
Issuance of common stock under stock incentive plans (in shares) 148,603      
Stock-based compensation expense   1,311   1,311
Net income (loss)     1,671 1,671
Balance at Jun. 30, 2022 $ 2 182,488 (149,225) 33,265
Balance (in shares) at Jun. 30, 2022 20,137,520      
Balance at Dec. 31, 2022 $ 2 185,364 (146,702) 38,664
Balance (in shares) at Dec. 31, 2022 20,374,288      
Increase (Decrease) in Stockholders' Equity        
Exercise of stock options   13   13
Exercise of stock options (in shares) 3,020      
Issuance of common stock under stock incentive plans (in shares) 157,436      
Stock-based compensation expense   1,160   1,160
Net income (loss)     761 761
Balance at Mar. 31, 2023 $ 2 186,537 (145,941) 40,598
Balance (in shares) at Mar. 31, 2023 20,534,744      
Balance at Dec. 31, 2022 $ 2 185,364 (146,702) $ 38,664
Balance (in shares) at Dec. 31, 2022 20,374,288      
Increase (Decrease) in Stockholders' Equity        
Exercise of stock options (in shares)       39,373
Net income (loss)       $ 4,646
Balance at Jun. 30, 2023 $ 2 188,126 (142,056) 46,072
Balance (in shares) at Jun. 30, 2023 20,743,422      
Balance at Mar. 31, 2023 $ 2 186,537 (145,941) 40,598
Balance (in shares) at Mar. 31, 2023 20,534,744      
Increase (Decrease) in Stockholders' Equity        
Exercise of stock options   148   148
Exercise of stock options (in shares) 36,353      
Issuance of common stock under stock incentive plans   181   181
Issuance of common stock under stock incentive plans (in shares) 172,325      
Stock-based compensation expense   1,260   1,260
Net income (loss)     3,885 3,885
Balance at Jun. 30, 2023 $ 2 $ 188,126 $ (142,056) $ 46,072
Balance (in shares) at Jun. 30, 2023 20,743,422